• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在弥散性小鼠白血病模型中利用切伦科夫发光成像对90钇和177镥放射性免疫缀合物进行体内定位

In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model.

作者信息

Balkin Ethan R, Kenoyer Aimee, Orozco Johnnie J, Hernandez Alexandra, Shadman Mazyar, Fisher Darrell R, Green Damian J, Hylarides Mark D, Press Oliver W, Wilbur D Scott, Pagel John M

机构信息

Radiation Oncology, University of Washington, Seattle, Washington.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

出版信息

Cancer Res. 2014 Oct 15;74(20):5846-54. doi: 10.1158/0008-5472.CAN-14-0764. Epub 2014 Sep 26.

DOI:10.1158/0008-5472.CAN-14-0764
PMID:25261237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199906/
Abstract

Cerenkov radiation generated by positron-emitting radionuclides can be exploited for a molecular imaging technique known as Cerenkov luminescence imaging (CLI). Data have been limited, however, on the use of medium- to high-energy β-emitting radionuclides of interest for cancer imaging and treatment. We assessed the use of CLI as an adjunct to determine localization of radioimmunoconjugates to hematolymphoid tissues. Radiolabeled (177)Lu- or (90)Y-anti-CD45 antibody (Ab; DOTA-30F11) was administered by tail vein injection to athymic mice bearing disseminated murine myeloid leukemia, with CLI images acquired at times afterward. Gamma counting of individual organs showed preferential uptake in CD45(+) tissues with significant retention of radiolabeled Ab in sites of leukemia (spleen and bone marrow). This result was confirmed in CLI images with 1.35 × 10(5) ± 2.2 × 10(4) p/s/cm(2)/sr and 3.45 × 10(3) ± 7.0 × 10(2) p/s/cm(2)/sr for (90)Y-DOTA-30F11 and (177)Lu-DOTA-30F11, respectively, compared with undetectable signal for both radionuclides using the nonbinding control Ab. Results showed that CLI allows for in vivo visualization of localized β-emissions. Pixel intensity variability resulted from differences in absorbed doses of the associated energies of the β-emitting radionuclide. Overall, our findings offer a preclinical proof of concept for the use of CLI techniques in tandem with currently available clinical diagnostic tools.

摘要

由发射正电子的放射性核素产生的切伦科夫辐射可用于一种称为切伦科夫发光成像(CLI)的分子成像技术。然而,关于用于癌症成像和治疗的中高能β发射放射性核素的使用数据有限。我们评估了CLI作为辅助手段来确定放射免疫缀合物在血液淋巴组织中的定位。通过尾静脉注射将放射性标记的(177)镥或(90)钇抗CD45抗体(Ab;DOTA - 30F11)给予患有播散性小鼠髓性白血病的无胸腺小鼠,随后在不同时间采集CLI图像。对各个器官进行γ计数显示,在CD45(+)组织中有优先摄取,放射性标记的Ab在白血病部位(脾脏和骨髓)有显著保留。在CLI图像中得到了证实,对于(90)钇 - DOTA - 30F11和(177)镥 - DOTA - 30F11,分别为1.35×10(5)±2.2×10(4)p/s/cm(2)/sr和3.45×10(3)±7.0×10(2)p/s/cm(2)/sr,而使用非结合对照抗体时两种放射性核素均未检测到信号。结果表明,CLI能够在体内可视化局部β发射。像素强度变异性是由β发射放射性核素相关能量的吸收剂量差异导致的。总体而言,我们的研究结果为将CLI技术与当前可用的临床诊断工具联合使用提供了临床前概念验证。

相似文献

1
In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model.在弥散性小鼠白血病模型中利用切伦科夫发光成像对90钇和177镥放射性免疫缀合物进行体内定位
Cancer Res. 2014 Oct 15;74(20):5846-54. doi: 10.1158/0008-5472.CAN-14-0764. Epub 2014 Sep 26.
2
Cerenkov luminescence imaging of medical isotopes.医学同位素的切伦科夫发光成像。
J Nucl Med. 2010 Jul;51(7):1123-30. doi: 10.2967/jnumed.110.076521. Epub 2010 Jun 16.
3
Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.在临床前放射性核素治疗中,利用切伦科夫发光成像进行治疗性生物动力学测量、剂量学参数估计及治疗效果监测。
J Nucl Med. 2015 Mar;56(3):444-9. doi: 10.2967/jnumed.114.148544. Epub 2015 Feb 5.
4
Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.用于计算90Y标记的胃泌素释放肽受体拮抗剂辐射剂量的切伦科夫发光成像
J Nucl Med. 2015 May;56(5):805-11. doi: 10.2967/jnumed.114.149054. Epub 2015 Apr 3.
5
Cerenkov luminescence imaging of αv β6 integrin expressing tumors using (90) Y-labeled peptides.使用(90)Y标记的肽对表达αvβ6整合素的肿瘤进行切伦科夫发光成像。
J Labelled Comp Radiopharm. 2014 Jul;57(9):558-65. doi: 10.1002/jlcr.3215. Epub 2014 Jul 8.
6
Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model.在神经母细胞瘤小鼠模型中,使用64Cu标记抗体进行体内和体外正电子发射断层扫描与切伦科夫发光成像之间的相关性。
Oncotarget. 2016 Oct 11;7(41):67403-67411. doi: 10.18632/oncotarget.11795.
7
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.(89)锆作为一种正电子发射断层扫描(PET)替代放射性同位素,用于在与内化抗体西妥昔单抗偶联后,在荷瘤裸鼠中探寻治疗性放射性金属(90)钇和(177)镥的生物分布。
J Nucl Med. 2005 Nov;46(11):1898-906.
8
Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.切伦科夫发光成像作为评估基于抗体的正电子发射断层显像放射性示踪剂的一种方式。
J Nucl Med. 2017 Jan;58(1):175-180. doi: 10.2967/jnumed.116.178780. Epub 2016 Aug 18.
9
Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.使用177镥或111铟标记的双特异性放射免疫偶联物对无胸腺小鼠中同时表达HER2和EGFR的人乳腺癌异种移植瘤进行双受体靶向放射免疫治疗。
J Nucl Med. 2016 Mar;57(3):444-52. doi: 10.2967/jnumed.115.162339. Epub 2015 Oct 1.
10
Cerenkov luminescence endoscopy: improved molecular sensitivity with β--emitting radiotracers.切伦科夫发光内镜检查:使用发射β射线的放射性示踪剂提高分子灵敏度。
J Nucl Med. 2014 Nov;55(11):1905-9. doi: 10.2967/jnumed.114.139105. Epub 2014 Oct 9.

引用本文的文献

1
Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy.光学(切伦科夫)剂量测定法用于揭示基于放射性同位素的治疗的放射生物学效应。
Eur J Nucl Med Mol Imaging. 2025 May;52(6):1955-1957. doi: 10.1007/s00259-024-07047-4.
2
A review of recent and emerging approaches for the clinical application of Cerenkov luminescence imaging.对切伦科夫发光成像临床应用的最新及新兴方法的综述。
Front Phys. 2021;9. doi: 10.3389/fphy.2021.684196. Epub 2021 Jul 28.
3
Cerenkov luminescence and PET imaging of Y: capabilities and limitations in small animal applications.切伦科夫发光和 PET 成像的 Y:在小动物应用中的能力和限制。
Phys Med Biol. 2020 Mar 20;65(6):065006. doi: 10.1088/1361-6560/ab7502.
4
Removal of random-valued impulse noise from Cerenkov luminescence images.从切伦科夫发光图像中去除随机值脉冲噪声。
Med Biol Eng Comput. 2020 Jan;58(1):131-141. doi: 10.1007/s11517-019-02069-9. Epub 2019 Nov 21.
5
3D-printed Wash Station with Integrated Anesthesia Delivery Manifold for High-throughput Depilation of Laboratory Mice.带有集成麻醉输送歧管的3D打印清洗站,用于实验室小鼠的高通量脱毛
J Am Assoc Lab Anim Sci. 2019 Jan 1;58(1):65-70. doi: 10.30802/AALAS-JAALAS-18-000037. Epub 2018 Dec 7.
6
Multimodality reporter gene imaging: Construction strategies and application.多模态报告基因成像:构建策略与应用。
Theranostics. 2018 Apr 18;8(11):2954-2973. doi: 10.7150/thno.24108. eCollection 2018.
7
Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes.使用临床相关同位素进行切伦科夫发光成像的实用指南。
Methods Mol Biol. 2018;1790:197-208. doi: 10.1007/978-1-4939-7860-1_15.
8
Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.用于癌症成像和放射性核素治疗的基于抗体的放射性药物的临床前优化——模型、载体和放射性核素选择。
J Labelled Comp Radiopharm. 2018 Jul;61(9):611-635. doi: 10.1002/jlcr.3612. Epub 2018 Mar 30.
9
Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences.切伦科夫发光成像:物理原理及其在生物医学科学中的潜在应用
EJNMMI Phys. 2017 Dec;4(1):14. doi: 10.1186/s40658-017-0181-8. Epub 2017 Mar 11.
10
Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model.在神经母细胞瘤小鼠模型中,使用64Cu标记抗体进行体内和体外正电子发射断层扫描与切伦科夫发光成像之间的相关性。
Oncotarget. 2016 Oct 11;7(41):67403-67411. doi: 10.18632/oncotarget.11795.

本文引用的文献

1
Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery.术中靶向光学成像:癌症手术中实现无肿瘤边缘的指导。
Curr Pharm Biotechnol. 2013;14(8):733-42. doi: 10.2174/1389201014666131226113300.
2
Clinical Cerenkov luminescence imaging of (18)F-FDG.临床 Cerenkov 光学生物发光断层显像技术在 18F-FDG 中的应用。
J Nucl Med. 2014 Jan;55(1):95-8. doi: 10.2967/jnumed.113.127266. Epub 2013 Sep 27.
3
Optimization of microfluidic PET tracer synthesis with Cerenkov imaging.应用切伦科夫成像优化微流控 PET 示踪剂合成。
Analyst. 2013 Oct 7;138(19):5654-64. doi: 10.1039/c3an01113e.
4
Superficial dosimetry imaging of Čerenkov emission in electron beam radiotherapy of phantoms.体模中电子束放射治疗的切伦科夫发射的表面剂量成像。
Phys Med Biol. 2013 Aug 21;58(16):5477-93. doi: 10.1088/0031-9155/58/16/5477. Epub 2013 Jul 24.
5
Čerenkov excited fluorescence tomography using external beam radiation.采用外照射辐射的切伦科夫受激荧光断层成像技术。
Opt Lett. 2013 Apr 15;38(8):1364-6. doi: 10.1364/OL.38.001364.
6
First human Cerenkography.首例人体正电子发射断层扫描。
J Biomed Opt. 2013 Feb;18(2):20502. doi: 10.1117/1.JBO.18.2.020502.
7
Cerenkov imaging - a new modality for molecular imaging.切伦科夫成像——分子成像的一种新方式。
Am J Nucl Med Mol Imaging. 2012;2(2):163-73. Epub 2012 Mar 28.
8
Endoscopic imaging of Cerenkov luminescence.切伦科夫发光的内镜成像。
Biomed Opt Express. 2012 Jun 1;3(6):1215-25. doi: 10.1364/BOE.3.001215. Epub 2012 May 3.
9
In vivo Cerenkov luminescence imaging: a new tool for molecular imaging.体内切伦科夫发光成像:分子成像的新工具。
Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4605-19. doi: 10.1098/rsta.2011.0271.
10
Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.MLN4924 治疗后在人淋巴瘤异种移植模型中进行(18)F-FDG PET 和切伦科夫发光成像的多模态成像。
J Nucl Med. 2011 Nov;52(11):1764-9. doi: 10.2967/jnumed.111.091710. Epub 2011 Oct 12.